| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/14/2011 | US20110172315 Composition for cryopreservation of cells and tissues |
| 07/14/2011 | US20110172295 METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING |
| 07/14/2011 | US20110172294 Cyclohexenyl nucleic acids analogs |
| 07/14/2011 | US20110172291 Rna interference for the treatment of gain-of-function disorders |
| 07/14/2011 | US20110172290 Isoforms of eIF-5A: Senescence-induced eIF5A; Wounding-induced elF-5A; Growth elF-5A; and DHS |
| 07/14/2011 | US20110172289 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 07/14/2011 | US20110172287 Compositions and methods for inhibiting tumor growth and metastasis |
| 07/14/2011 | US20110172285 Proteasome inhibitors |
| 07/14/2011 | US20110172278 Compounds and methods for modulating g protein-coupled receptors |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172234 Methods and compositions of trail-death receptor agonists/activators |
| 07/14/2011 | US20110172233 Sonic hedgehog modulators |
| 07/14/2011 | US20110172206 Compositions and methods for treatment of neurodegenerative disease |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172165 Modified linkers |
| 07/14/2011 | US20110172150 Tissue regeneration method |
| 07/14/2011 | US20110172148 Periostin-induced pancreatic regeneration |
| 07/14/2011 | US20110172121 Allogeneic stem cell bank |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110172107 Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby |
| 07/14/2011 | US20110171733 Bovine Immunodeficiency Virus (BIV) Based Vectors |
| 07/14/2011 | US20110171732 Highly porous solid material made of biodegradable polymer and method of fabricating, processing, and cell-seeding the same |
| 07/14/2011 | US20110171731 Compositions containing platelet contents |
| 07/14/2011 | US20110171730 Conjugates For Use In Hepatocyte Free Uptake Assays |
| 07/14/2011 | US20110171729 Method for Producing Stable Mammalian Cell Lines Producing High Levels of Recombinant Proteins |
| 07/14/2011 | US20110171728 Method and composition for crystallizing G protein-coupled receptors |
| 07/14/2011 | US20110171727 Compositions and methods for activating genes of interest |
| 07/14/2011 | US20110171726 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same |
| 07/14/2011 | US20110171712 Self-assembling tissue modules |
| 07/14/2011 | US20110171702 Recombinant cell producing 2-hydroxyisobutyric acid |
| 07/14/2011 | US20110171698 C-22 hydroxylase |
| 07/14/2011 | US20110171693 Amylases, nucleic acids encoding them and methods for making and using them |
| 07/14/2011 | US20110171689 Artificial immune system: methods for making and use |
| 07/14/2011 | US20110171688 Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| 07/14/2011 | US20110171686 Reverse cumate repressor mutant |
| 07/14/2011 | US20110171681 Methods and compositions for regulation of stem cell survival, proliferation, and differentiation by protein ubiquitination |
| 07/14/2011 | US20110171675 Fret-based membrane-type 1 matrix metalloproteinase biosensor and methods for using the same |
| 07/14/2011 | US20110171663 Microtrench and tumour proliferation assay |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171624 Media solutions and methods for cryopreservation and thawing of in vitro fertilization specimens |
| 07/14/2011 | US20110171453 Immunoneutral silk-fiber-based medical devices |
| 07/14/2011 | US20110171314 Non-viral compositions and methods for transfecting gut cells in vivo |
| 07/14/2011 | US20110171287 Use of Oligonucleotides with Modified Bases as Antiviral Agents |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171262 Parvoviral capsid with incorporated gly-ala repeat region |
| 07/14/2011 | US20110171256 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171242 Ligand for herpes simplex virus entry mediator and methods of use |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171234 Vaccine |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171229 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171221 Compositions and methods for the treatment of a neoplasia |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171216 Monoclonal antibodies specific for pancreatic neoplasia cells |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171213 Methods for treating pancreatic cancer |
| 07/14/2011 | US20110171211 Heat shock protein gp96 vaccination and methods of using same |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171204 Antibodies to ntb-a |
| 07/14/2011 | US20110171198 Highly functional enzyme having alpha-galactosidase activity |
| 07/14/2011 | US20110171197 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 07/14/2011 | US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) |
| 07/14/2011 | US20110171183 Markers of Induced Pluripotent Stem Cells |
| 07/14/2011 | US20110171180 Bioengineered skin substitutes |
| 07/14/2011 | US20110171179 Method for Regulating Production of Hemoglobin Beta Chains |
| 07/14/2011 | US20110171177 Compositions and Methods for Inhibiting Entry of a Hepatic Virus |
| 07/14/2011 | US20110171175 Inhibitors of serine proteases |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171133 Radiolabelled mmp selective compounds |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 07/14/2011 | US20110167602 Immunoneutral silk-fiber-based medical devices |
| 07/14/2011 | DE102009040716B4 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells |
| 07/14/2011 | CA2786741A1 Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
| 07/14/2011 | CA2786664A1 Vectors and methods for transducing b cells |
| 07/14/2011 | CA2786659A1 Mouse artificial chromosome vector |
| 07/14/2011 | CA2786400A1 Biomaterials made from human hair |
| 07/14/2011 | CA2786383A1 Jatropha hybrids through female only trait |
| 07/13/2011 | EP2343367A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343366A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343365A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343364A2 Tubulin regulatory elements for use in plants |
| 07/13/2011 | EP2343362A1 Improved process for the culturing of cells |
| 07/13/2011 | EP2343361A1 Cell culture kit, screening method, and cell culture kit manufacturing method |
| 07/13/2011 | EP2343318A2 Antibodies binding to a C-terminal fragment of Apolipoprotein E |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2343079A2 Cell suspension preparation device |
| 07/13/2011 | EP2342350A1 Method for polyclonal immunoglobulin g production by human b cells |